Penny Stocks, Trade Alerts and Profits

Breaking News and Trade Alerts

Guess who has a 8.5% stake in $HTZ ?

Carl Icahn does. And he is now the biggest shareholder in Hertz (HTZ)   This from Fox Business News:    Icahn discloses 8.5-pct stake in Hertz, plans to have talks with rental car company Activist investor Carl Icahn has taken an 8.5-percent stake in Hertz, which would make him the rental car company’s biggest shareholder. […]

Click this link to read the original post on StockGuru.com: Guess who has a 8.5% stake in $HTZ ?

Content from StockGuru.com is syndicated on over 1000 web sites and we welcome syndication as long as a valid link to StockGuru.com appears on the site. Copyright 2003 through 2013 with All rights protected unless a working link to StockGuru.com is enabled in the post. Contact us at: [email protected] – (469) 358-5200.

Categories:

Tags:

(Read more on StockGuru.com)

Content from StockGuru.com is syndicated on over 1000 web sites and we welcome syndication as long as a valid link to StockGuru.com appears on the site. Copyright 2003 through 2013 with All rights protected unless a working link to StockGuru.com is enabled in the post. Contact us at: [email protected] – (469) 358-5200.

H-P Up in Sales, But Profits Fall Short

 This from Fox Business News: Hewlett-Packard on Wednesday reported a fiscal third-quarter profit of $985 million, or 52 cents a share, compared with a profit of $1.39 billion, or 71 cents a share, for the year-earlier period. Click this link to read the original post on StockGuru.com: H-P Up in Sales, But Profits Fall ShortContinue Reading

Dow Up Three Days in a Row

Third day up on the dow. Central bank officials are pushing for higher interest rates far sooner than anticipated.    Click this link to read the original post on StockGuru.com: Dow Up Three Days in a Row Content from StockGuru.com is syndicated on over 1000 web sites and we welcome syndication as long as aContinue Reading

Pharma Update: $RCHA $SKVI

Important Pharmaceutical Updates: Rich Pharmaceuticals (OTCQB: RCHA) moves to OTCQB. Skinvisible Pharmaceuticals (OTCBB: SKVI) Announces additional details on its Networking Marketing subsidiary, Kintari.  First – RCHA: Rich Pharmaceuticals, Inc. (OTCQB: RCHA) is verified for trading on OTCQB®, the venture stage marketplace for early and developing companies, as of August 18, 2014. Rich Pharmaceuticals is a biopharmaceutical company thatContinue Reading

More About Skinvisible $SKVI and Kintari, The New Network Marketing Subsidiary

Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success.  Kintari is aboveContinue Reading

More About Skinvisible $SKVI and Kintari, The New Network Marketing Subsidiary

Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success.  Kintari is aboveContinue Reading

Skinvisible $SKVI Appoints Rob Barns as Kintari Director of Sales

Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success.  Kintari is aboveContinue Reading

Skinvisible $SKVI and Kintari Expands Team of Experts – Key Direct Sales and Production Staff Added

Skinvisible and Kintari Expands Team of Experts Key Direct Sales and Production Staff Added Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari, is pleased to announce the addition of Rob Barnes as Director of Sales. Rob will lead Kintari’s sales globally. Rob brings over two decades of direct sales experience to Kintari’sContinue Reading